Diabetic macular edema (DME) is the most common cause. Effect of Diabetic Macular Edema on Peripapillary Retinal Nerve Fiber Layer Thickness Profiles
|
|
- Brendan Ferguson
- 5 years ago
- Views:
Transcription
1 Retina Effect of Diabetic Macular Edema on Peripapillary Retinal Nerve Fiber Layer Thickness Profiles Duck Jin Hwang, 1,2 Eun Ji Lee, 1 Sang Yoon Lee, 3 Kyu Hyung Park, 1 and Se Joon Woo 1 1 Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea 2 HanGil Eye Hospital, Incheon, Korea 3 Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea Correspondence: Se Joon Woo, Department of Ophthalmology, Seoul National University Bundang Hospital, #300, Gumi-dong, Bundang-gu, Seongnam, Gyeonggi-do , Korea; sejoon1@snu.ac.kr. Submitted: December 16, 2013 Accepted: April 30, 2014 Citation: Hwang DJ, Lee EJ, Lee SY, Park KH, Woo SJ. Effect of diabetic macular edema on peripapillary retinal nerve fiber layer thickness profiles. Invest Ophthalmol Vis Sci. 2014;55: DOI: / iovs PURPOSE. To investigate both the effect of diabetic macular edema (DME) on measured peripapillary retinal nerve fiber layer (RNFL) thickness and the effect of intravitreal bevacizumab injection on RNFL thickness using spectral-domain optical coherence tomography (SD-OCT) in patients with diabetic retinopathy. METHODS. We compared the SD-OCT RNFL thickness profiles between eyes with and without DME (DME [n ¼ 42]; without DME [n ¼ 53]) and conducted an interventional study for evaluating the effect of DME on RNFL thickness. Six sectorial and the global RNFL (grnfl) thicknesses were compared between the two groups. To evaluate the intraindividual effect of DME on RNFL thickness, 1-month follow-up OCT data of 42 eyes that received an intravitreal bevacizumab injection were compared with preinjection data. RESULTS. The six sectorial and grnfl thicknesses were greater in the DME group than the non- DME group (P < 0.05). The grnfl thickness significantly correlated with the central foveal thickness (CFT) (R ¼ 0.470, P < 0.001) and total macular volume (R ¼ 0.786, P < 0.001). The 42 eyes that received intravitreal bevacizumab injections showed significant decreases of the CFT (P < 0.001) and grnfl thickness (P < 0.001) after injection. Additionally, the changes in macular thickness and RNFL thickness were significantly correlated (R ¼ 0.576, P < 0.001). CONCLUSIONS. The RNFL thickness was generally increased in patients with DME, and the increment correlated with the degree of macular edema. While long-lasting DME resulted in RNFL thickening in all sectors, short-term DME resolution mainly influenced the temporal and nasal RNFL thicknesses. Cautious interpretation is recommended for evaluation of glaucoma using RNFL thickness in diabetic patients, especially patients with DME. Keywords: diabetic macular edema, glaucoma, retinal nerve fiber layer thickness Diabetic macular edema (DME) is the most common cause of visual impairment and legal blindness in patients with diabetes mellitus (DM). 1 The pathogenesis of DME is rather complex and is still not fully understood. It occurs mainly because of disruption of the blood retinal barrier, which leads to increased fluid accumulation within the intraretinal layers of the macula. 2 Glaucoma is a progressive optic neuropathy characterized by progressive loss of retinal ganglion cells (RGC) and the retinal nerve fiber layer (RNFL) with or without associated visual field loss. 3 Because glaucomatous optic nerve damage is largely irreversible, early detection of the disease and its progression is crucial in glaucoma management. It has been shown that quantitative RNFL thickness measurement using optical coherence tomography (OCT) is a valuable tool for the early diagnosis of glaucoma 4,5 as well as for monitoring glaucoma progression. 6,7 With the advent of spectral-domain (SD)-OCT, which facilitates the segmentation of the retina and quantification of RNFL thickness with better resolution, it has been recently demonstrated that the sensitivity and specificity for diagnosis and progression detection can be significantly improved. 8,9 According to a few previous studies, 10,11 DME may affect other parts of the eye in addition to the macula. Funatsu et al. 10 reported that the vitreous vascular endothelial growth factor (VEGF) level was higher in subjects with DME compared to that in control subjects. Further, we previously reported that temporary macular edema after panretinal photocoagulation accompanied a transient increase in peripapillary RNFL thickness, 11 providing indirect evidence that DME may have an effect on RNFL thickness profiles. However, to the best of our knowledge, no prior study has addressed the possible effects of DME on the RNFL thickness assessment. Such information is clinically important because individuals with diabetes are at a higher risk of having glaucoma than people without diabetes: The rate of glaucoma was 7.8% in people with diabetes compared to 3.9% in nondiabetic individuals in a population-based study. 12 Therefore, the aim of this study was to compare the peripapillary RNFL thickness in diabetic patients with DME to that in patients without DME and to investigate whether the fluctuation in DME with intravitreal drug injections changes the peripapillary RNFL thickness parameters. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc. j ISSN:
2 Effect of DME on RNFL Profiles IOVS j July 2014 j Vol. 55 j No. 7 j 4214 METHODS Subjects We included 95 eyes of 95 patients (42 patients with DME and 53 age- and diabetes duration matched patients with diabetic retinopathy without DME) in this case-control study. We retrospectively reviewed the charts of patients diagnosed with diabetic retinopathy at the Seoul National University Bundang Hospital from September 2012 to February Patients who met the following inclusion criteria were included consecutively: (1) age greater than 30 years and (2) diagnosed with clinical evidence of diabetic retinopathy with/without DME. Diabetic macular edema was defined as a central foveal thickness (CFT) 350 lm on OCT. The major exclusion criteria were as follows: (1) history of or clinical evidence of glaucoma; (2) presence of vitreous hemorrhage; (3) presence of another retinal disease except for diabetic retinopathy, that is, other conditions that can cause macular thickening such as retinal vein occlusion, epiretinal membrane, or vitreomacular traction or age-related macular degeneration; (4) previous treatment for DME with focal/grid laser or intravitreal injection within 6 months; (5) history of panretinal photocoagulation; (6) any intraocular surgery within 6 months or previous pars plana vitrectomy; and (7) severe cataracts or media opacity, which could have an influence on performing OCT. All 42 eyes with DME received an intravitreal bevacizumab injection for the treatment of DME. To evaluate the intraindividual effect of DME on RNFL thickness, 42 eyes that received intravitreal bevacizumab injections for DME were retrospectively included in the interventional cohort study. The macular thickness and volume profiles of the retina and choroid were measured at baseline (preinjection) and 1 month after a single bevacizumab injection. When both eyes were eligible for the study, the eye with more severe DME was selected. Optical Coherence Tomography Scanning Protocols An SD-OCT examination with macular thickness mapping and circumpapillary RNFL thickness measurements was performed by using Spectralis OCT (Heidelberg Engineering, Heidelberg, Germany). The circumpapillary RNFL thickness was measured in six sectors: temporal (T, ), superior temporal (TS, ), superior nasal (NS, ), nasal (N, ), inferior nasal (NI, ), and inferior temporal (TI, ), together with the papillomacular bundle (PMB, 338 8; Spectralis Nsite Axonal Analytics Software; Heidelberg Engineering) thickness. The global RNFL thickness was obtained by averaging the total 3608 RNFL thicknesses. The RNFL thickness parameters were compared between the DME group and the non-dme group. In addition, the relationship between RNFL profiles and macular thickness was evaluated. All eyes with DME underwent Spectralis OCT before and after a single intravitreal injection of bevacizumab. A central volume scan with a 25-scan pattern and macular thickness map protocols was performed. The macular thickness maps were divided into nine sectors according to the Early Treatment Diabetic Retinopathy Study (ETDRS) layout, namely, the 1,000- lm central ring and each of the four quadrants of an inner ring and an outer ring. Additionally, a volumetric assessment of the central retinal structures consisting of 25 single horizontal axial scans was performed (scanning area: mm, centered at the fovea). The global RNFL thickness and the peripapillary RNFL thicknesses of the six sectors were compared between preand 1-month postinjection values. Intravitreal Injection Methods All injections were performed within 1 week after performance of the OCT examination. Under topical anesthesia with proparacaine (0.5%) eye drops, the bulbar conjunctiva and fornices were rinsed with 5% povidone-iodine, followed by application of a sterile drape and lid speculum. After applying a drop of 5% povidone-iodine, 1.25 mg (0.05 ml) bevacizumab was injected via the pars plana. The needle was removed carefully, and the injection site was compressed with a sterile cotton applicator to prevent reflux. Antibiotic eye drops were applied four times per day for 3 days after the injection. Ethics Statement The study was approved by the institutional review board of Seoul National University Bundang Hospital, and the study was carried out in accordance with the tenets of the Declaration of Helsinki. Statistical Analysis Statistical analyses were performed using a commercially available software package (IBM SPSS Statistics 18; SPSS, Inc., Chicago, IL, USA). In the comparative study, significant differences in the CFT and macular volume between the DME and non-dme groups were evaluated using the independent t-test and the Mann-Whitney test for parametric and nonparametric data, respectively. Additionally, the relationship between the RNFL thickness profiles and macular thickness was evaluated by Pearson s correlation analysis. In the interventional cohort study, significant differences between baseline and 1 month after intravitreal bevacizumab injection were evaluated using the paired t-test. Continuous variables are presented as the mean 6 standard deviation. Statistical significance was defined as P < RESULTS The baseline characteristics of 95 patients with diabetic retinopathy are summarized in Table 1. The mean age was years; the mean DM duration was years; and the averaged hemoglobin A1c (HbA1c) level was %. The mean 6 standard deviation of the visual acuity, converted to the logarithm of the minimal angle of resolution (logmar), was in the DME group and in the non-dme group (P < 0.001). No statistically significant differences in age, sex, DM duration, history of hypertension, HbA1c, baseline IOP, or refractive errors were observed (all P > 0.05). The CFT was 73.4% thicker in the DME group ( lm) than in the non-dme group ( lm, P < 0.001). Significant differences in RNFL thickness profiles were found between the DME and non-dme groups (Table 1, Figs. 1, 2). The global RNFL thickness was 37.4% greater in the DME group ( lm) compared to the non-dme group ( lm, P < 0.001). Further, the RNFL thickness of all six sectors was greater in the DME group than in the non-dme group (P < 0.001). The difference in RNFL thickness was largest in the temporal sector (46.4 lm), followed by the nasal (40.9 lm), superior nasal (36.3 lm), inferior nasal (32.9 lm), superior temporal (32.12 lm), and inferior temporal (18.0 lm) sectors. The global RNFL thickness was significantly correlated with the CFT (R ¼ 0.470, P < 0.001) and total macular volume (R ¼ 0.786, P < 0.001) (Fig. 3). In 42 DME eyes that received a single intravitreal injection, significant decreases in the CFT ( lm, P < 0.001) and RNFL thickness ( lm, P < 0.001) were
3 Effect of DME on RNFL Profiles IOVS j July 2014 j Vol. 55 j No. 7 j 4215 TABLE 1. Comparison of Patients With Diabetic Retinopathy With and Without DME in the Case-Control Study Total, N ¼ 95 Eyes DME Group, N ¼ 42 Eyes Non-DME Group, N ¼ 53 Eyes DME/Non-DME Ratio, % P Value Base characteristics Age, y * Female (%) 43 (45.3) 23 (54.8) 20 (37.7) Male (%) 52 (54.7) 19 (45.2) 33 (62.3) DM duration, y * HTN, N (%) 37 (38.9) 18 (42.9) 19 (35.8) HbA1c, % * IOP, mm Hg * SE, diopters * VA, logmar <0.001* Macular thickness/volume Central foveal thickness, lm <0.001* Total macular volume, mm <0.001* RNFL thickness, lm Global <0.001* PMB * Temporal <0.001* Nasal <0.001* Superotemporal <0.001* Inferotemporal * Superonasal * Inferonasal <0.001* DME/non-DME ratio (%) indicates the value of parameters of the DME group/value of the parameters of the non-dme group. The values represent means 6 standard deviation. HTN, hypertension; SE, spherical equivalent; VA, visual acuity. * P values calculated by the independent t-test and the Mann-Whitney test for parametric and nonparametric data. P values calculated by Pearson s v 2 test. Values in bold are statistically significant (P < 0.05). FIGURE 1. Peripapillary RNFL thickness profiles measured by Spectralis OCT were compared between the DME group and the non-dme group. The DME group had higher thickness profiles in global RNFL thickness and total RNFL sectors (P < 0.05). The pre- and postinjection RNFL parameters of the DME group were higher compared to those of the non-dme group in total sectors. The reduction in the RNFL thickness after intravitreal bevacizumab injection was significant in the temporal and nasal sectors and the papillomacular bundle (PMB) (P < 0.05).
4 Effect of DME on RNFL Profiles IOVS j July 2014 j Vol. 55 j No. 7 j 4216 FIGURE 2. The non-dme group and DME group were compared as shown in Spectralis OCT RNFL profiles and macular thickness maps. (A) Case 1: 40-year-old man with proliferative diabetic retinopathy (PDR) without DME in whom the diabetes duration was 7 years and HbA1c was 11.3%. His RNFL thickness profile was normal. (B) Case 2: 68-year-old man with severe nonproliferative diabetic retinopathy with DME in whom the diabetes duration was 4 years and the HbA1c was 6.8%. The RNFL thicknesses of all sectors except for the superior nasal sector were thicker than the normal range. (C) The values before and after a single intravitreal bevacizumab injection were compared in the case 2 patient. The RNFL thicknesses of all six sectors and the macular thickness decreased 1 month after a single injection. observed 1 month after intravitreal bevacizumab injection. The mean CFT was lm before injection and decreased to lm at 1 month after injection (P < 0.001) (Table 2, Fig. 2). The total macular volume of all ETDRS subfields was decreased at 1 month after injection ( mm 3 ) compared with that before injection ( mm 3, P < 0.001). The global RNFL thicknesses at pre- and post injection were lm and lm, respectively (P < 0.001). The changes in the RNFL thicknesses of the temporal and nasal sectors were significant (Table 2, FIGURE 3. (A, B) Global RNFL thickness was significantly correlated with the central foveal thickness (CFT) and total macular volume. The total macular volume showed a stronger correlation with the global RNFL thickness (R ¼ 0.786, P < 0.001) than with the CFT (R ¼ 0.470, P < 0.001).
5 Effect of DME on RNFL Profiles IOVS j July 2014 j Vol. 55 j No. 7 j 4217 TABLE 2. Comparison Between Pre- and Postinjection Parameters for Central Foveal Thickness, Total Macular Volume, and RNFL Thickness Profiles in the Interventional Cohort Study Preinjection, N ¼ 42 Eyes Postinjection, N ¼ 42 Eyes Post-Pre ratio, % P Value* Macular thickness/volume Central foveal thickness, lm <0.001 Total macular volume, mm <0.001 RNFL thickness, lm Global <0.001 PMB Temporal Nasal Superior temporal Inferior temporal Superior nasal Inferior nasal Post-pre ratio (%) indicates postinjection value/preinjection value. * P values calculated using the paired t-test. Values in bold are statistically significant (P < 0.05). Fig. 1). A significant amount of reduction in the sectorial RNFL thickness was found in the temporal ( lm, P ¼ 0.012) and nasal ( lm, P ¼ 0.003) sectors, followed by the superior temporal ( lm, P ¼ 0.088), superior nasal ( lm, P ¼ 0.173), inferior nasal ( lm, P ¼ 0.058), and inferior temporal ( lm, P ¼ 0.651) sectors. The global RNFL thickness change after intravitreal bevacizumab injection was significantly correlated with the change in the mean CFT (R ¼ 0.576, P < 0.001) and total macular volume (R ¼ 0.634, P < 0.001) (Fig. 4). Significant differences in the RNFL thickness profiles were observed between the DME and non-dme groups even after a single intravitreal bevacizumab injection (Table 3, Fig. 1). DISCUSSION In the current study, we demonstrated a significant difference in the RNFL thickness profiles between the DME group and non-dme group. The RNFL thicknesses of all six sectors were greater in the DME group than in the non-dme group, and the average increase in thickness was 37.4%. Additionally, shortterm improvement of DME following a single intravitreal injection of bevacizumab significantly decreased temporal and nasal RNFL thicknesses. In summary, chronic DME had an effect on the overall RNFL thickness profiles and had an effect mainly on the temporal and nasal RNFL thicknesses and PMB thickness in the short term (1 month). It is well known that glaucomatous change is mainly associated with decrement in the superior temporal or inferior temporal RNFL thickness. 13 However, our results indicate that long-term sustained DME influences the increment of the superior or inferior RNFL thickness as well as the temporal or nasal RNFL thickness. Therefore, because the OCT RNFL thickness is greater in patients with DME, careful interpretation may be required when one is evaluating glaucomatous RNFL damage in those patients. The increment of RNFL thickness was significantly correlated with the severity of DME in the current study. The exact etiology for the change of RNFL thickness profiles in patients with DME remains unclear. Because the breakdown of the blood retinal barrier (BRB) is the final common pathway in the formation of DME, 14 it is possible that the breakdown of the inner BRB in RNFL causes RNFL edema, which then results in the increase of RNFL thickness. In addition, the reduction in RNFL thickness after intravitreal bevacizumab injection was largest in the temporal sector, which may be related to the change of macular tomography according to the resolution of macular edema. From our study results, we can hypothesize TABLE 3. Comparison Between the Parameters of the Non-DME Group and the Postinjection Parameters of the DME Group Non-DME Group, N ¼ 53 Eyes DME Group, Postinjection, N ¼ 42 Eyes DME/Non-DME Ratio, % P Value* Macular thickness/volume Central foveal thickness, lm <0.001 Total macular volume, mm <0.001 RNFL thickness, lm Global <0.001 PMB <0.001 Temporal <0.001 Nasal <0.001 Superior temporal Inferior temporal Superior nasal <0.001 Inferior nasal <0.001 DME/non-DME ratio (%) indicates the value of the postinjection parameters of the DME group/value of the parameters of the non-dme group. * P values calculated using the paired t-test. Values in bold are statistically significant (P < 0.05).
6 Effect of DME on RNFL Profiles IOVS j July 2014 j Vol. 55 j No. 7 j 4218 FIGURE 4. The change in central foveal thickness (A) and total macular volume (B) correlated significantly with the change in the RNFL thickness after a single intravitreal bevacizumab injection (R ¼ 0.576, P < 0.001; R ¼ 0.634, P < 0.001, respectively). that acute DME first results in temporal RNFL edema/ thickening, followed by or coincident with the increment of nasal RNFL thickness; in contrast, the RNFL edema diffuses into all peripapillary sectors in subacute or chronic DME, causing a generalized increase in RNFL thickness. It is possible that no changes of RNFL thickness actually occurred in DME and that this finding can be explained by factors such as scanning error, diurnal fluctuation in RNFL due to the effect of diabetes, or the repeatability or reproducibility of OCT. Therefore, we examined each of the OCT scans in an attempt to identify a specific RNFL layer that showed notable errors of automatic segmentation in measuring thickness in patients with DME. However, this was not found for any participants, and no segmentation errors were observed. To the best of our knowledge, the present study is the first clinical study to report the effect of DME on peripapillary RNFL thickness. We evaluated peripapillary RNFL thickness profiles to provide insights into the interpretation of RNFL parameters for the diagnosis of glaucoma and for the detection of its progression. Somfai et al. 15 reported that the RNFL layer showed no change in eyes with DME using the retinal layer segmentation method. However, these authors did not evaluate peripapillary RNFL thickness. Although several studies, 12,16 18 including a meta-analysis, 18 have shown an association between DM and glaucoma, and a clinic-based report 19 suggested that patients with diabetic retinopathy are more likely to have a thinner RNFL, no report has demonstrated the impact of DME on RNFL profiles for evaluating glaucoma. This issue should be taken into account when one is assessing the RNFL in patients with DME because many patients with diabetic retinopathy have DME, which can occur at any stage of nonproliferative and proliferative diabetic retinopathy, and because many patients with diabetes or diabetic retinopathy also may have glaucoma. 12 Although a definitive causal relationship between RNFL thickness and macular thickness has not been confirmed in diabetic retinopathy, we observed that the RNFL thickness tended to increase with an increase in DME in the current study. When a normal parameter in RNFL thickness is detected in a diabetic glaucoma patient or a diabetic patient with DME, the effect of DME on RNFL thickness profiles should be considered before progression of glaucomatous damage is precluded in these patients. We are aware that our study has several limitations. First, because this was a retrospective study enrolling patients visiting a single hospital, a selection bias inherent to retrospective studies may have been present. Second, the glaucoma evaluation is performed by combining various structural and functional tests, especially the visual field test; it does not rely solely on the RNFL thickness measurement. Thus, the absence of visual field test results is a study limitation with respect to the interpretation of the RNFL thickness data. Third, we evaluated the RNFL thickness parameters of patients who received intravitreal bevacizumab injections and correlated this result to the short-term effect of DME on RNFL thickness. From this result, we can obtain knowledge regarding the RNFL thickness change after the resolution of DME, but not after the development of DME. Thus, extrapolation of the RNFL thickness change during acute development of DME is a potential bias and must be confirmed in a prospective cohort study. Fourth, we did not take into account other factors that affect the peripapillary RNFL, such as a larger neuroretinal rim, shorter axial length, thicker subfoveal choroid, larger optic disc, and flatter anterior cornea. 20 Finally, although we showed that DME alters the RNFL thickness profile, we cannot be certain that the altered profiles are clinically significant. A quantitative analysis on the errors in glaucoma evaluation should be further elucidated in future clinical studies. In conclusion, RNFL thickness was generally increased in diabetic patients with DME, indicating that DME could mask the decrease in RNFL thickness, and this increment in RNFL thickness was significantly correlated with the severity of DME. Moreover, short-term DME changes mainly influenced the temporal and nasal RNFL thickness profiles. Although further studies will be required to confirm the clinical implications, we suggest that caution be used in interpretation of RNFL thickness parameters in diabetic patients with DME. Acknowledgments Supported by a grant (2012R1A2A2A ) funded by the National Research Foundation in Korea. The authors alone are responsible for the content and writing of the paper. Disclosure: D.J. Hwang, None; E.J. Lee, None; S.Y. Lee, None; K.H. Park, None; S.J. Woo, None
7 Effect of DME on RNFL Profiles IOVS j July 2014 j Vol. 55 j No. 7 j 4219 References 1. Fong DS, Ferris FL III, Davis MD, Chew EY. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1999;127: Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol. 1999;14: Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254: Jeoung JW, Park KH, Kim TW, Khwarg SI, Kim DM. Diagnostic ability of optical coherence tomography with a normative database to detect localized retinal nerve fiber layer defects. Ophthalmology. 2005;112: Chang RT, Knight OJ, Feuer WJ, Budenz DL. Sensitivity and specificity of time-domain versus spectral-domain optical coherence tomography in diagnosing early to moderate glaucoma. Ophthalmology. 2009;116: Lee EJ, Kim TW, Park KH, Seong M, Kim H, Kim DM. Ability of Stratus OCT to detect progressive retinal nerve fiber layer atrophy in glaucoma. Invest Ophthalmol Vis Sci. 2009;50: Lee EJ, Kim TW, Weinreb RN, Park KH, Kim SH, Kim DM. Trend-based analysis of retinal nerve fiber layer thickness measured by optical coherence tomography in eyes with localized nerve fiber layer defects. Invest Ophthalmol Vis Sci. 2011;52: Leung CK, Yu M, Weinreb RN, Lai G, Xu G, Lam DS. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: patterns of retinal nerve fiber layer progression. Ophthalmology. 2012;119: Wessel JM, Horn FK, Tornow RP, et al. Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54: Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology. 2003;110: Kim J, Woo SJ, Ahn J, Park KH, Chung H, Park KH. Long-term temporal changes of peripapillary retinal nerve fiber layer thickness before and after panretinal photocoagulation in severe diabetic retinopathy. Retina. 2012;32: Klein BE, Klein R, Jensen SC. Open-angle glaucoma and olderonset diabetes. The Beaver Dam Eye Study. Ophthalmology. 1994;101: Na JH, Sung KR, Baek S, et al. Detection of glaucoma progression by assessment of segmented macular thickness data obtained using spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53: Singh A, Stewart JM. Pathophysiology of diabetic macular edema. Int Ophthalmol Clin. 2009;49: Somfai GM, Tatrai E, Ferencz M, Puliafito CA, Debuc DC. Retinal layer thickness changes in eyes with preserved visual acuity and diffuse diabetic macular edema on optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2010;41: Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology. 1997;104: Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 1995;102: Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med. 2004;21: Takahashi H, Goto T, Shoji T, Tanito M, Park M, Chihara E. Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry. Am J Ophthalmol. 2006;142: Wang YX, Pan Z, Zhao L, You QS, Xu L, Jonas JB. Retinal nerve fiber layer thickness. The Beijing Eye Study PLoS ONE. 2013;8:e66763.
Retinal Nerve Fiber Layer Measurements in Myopia Using Optical Coherence Tomography
Original Article Philippine Journal of OPHTHALMOLOGY Retinal Nerve Fiber Layer Measurements in Myopia Using Optical Coherence Tomography Dennis L. del Rosario, MD and Mario M. Yatco, MD University of Santo
More informationEFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA
Basrah Journal Of Surgery EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA Salah Zuhair Abed Al-Asadi MB,ChB, FICMS, Lecturer, Department of Surgery, College
More informationClinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome
Hindawi Publishing Corporation Journal of Ophthalmology Volume 215, Article ID 62372, 5 pages http://dx.doi.org/1.1155/215/62372 Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic
More informationAdvances in OCT Murray Fingeret, OD
Disclosures Advances in OCT Murray Fingeret, OD Consultant Alcon, Allergan, Bausch & Lomb, Carl Zeiss Meditec, Diopsys, Heidelberg Engineering, Reichert, Topcon Currently Approved OCT Devices OCT Devices
More informationComparison of Retinal Nerve Fiber Layer Thickness between Stratus and Spectralis OCT
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2011;25(3):166-173 DOI: 10.3341/kjo.2011.25.3.166 Original Article Comparison of Retinal Nerve Fiber Layer Thickness between Stratus and Spectralis
More informationStudy of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema
Original Research Article Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema Neha Kantilal Desai 1,*, Somesh Vedprakash Aggarwal 2, Sonali
More informationTranslating data and measurements from stratus to cirrus OCT in glaucoma patients and healthy subjects
Romanian Journal of Ophthalmology, Volume 60, Issue 3, July-September 2016. pp:158-164 GENERAL ARTICLE Translating data and measurements from stratus to cirrus OCT in glaucoma patients and healthy subjects
More informationROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS
ORIGINAL ARTICLE ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS Aggarwal Somesh VP 1, Shah Sonali N 2, Bharwada Rekha M 3,
More informationA retrospective nonrandomized study was conducted at 3
Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine 1, Seoul, Korea Hangil Eye Hospital 2, Incheon, Korea Seoul National University Bundang Hospital 3, Seongnam,
More informationEfficacy of intravitreal bevacizumab (Avastin TM ) for shortterm treatment of diabetic macular edema
111 ORIGINAL Efficacy of intravitreal bevacizumab (Avastin TM ) for shortterm treatment of diabetic macular edema Toshihiko Nagasawa, Takeshi Naito, Shingo Matsushita, Hiroyuki Sato, Takashi Katome, and
More informationChanges in Peripapillary Retinal Nerve Fiber Layer Thickness after Pattern Scanning Laser Photocoagulation in Patients with Diabetic Retinopathy
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2014;28(3):220-225 http://dx.doi.org/10.3341/kjo.2014.28.3.220 Original Article Changes in Peripapillary Retinal Nerve Fiber Layer Thickness after
More informationLongitudinal Changes of Retinal Thicknesses in Branch Retinal Artery Occlusion: Spectral-Domain Optical Coherence Tomography Study METHODS.
Retina Longitudinal Changes of Retinal Thicknesses in Branch Retinal Artery Occlusion: Spectral-Domain Optical Coherence Tomography Study Min-Su Kim, 1 Kyeung-Min Kim, 1 Hyung-Bin Lim, 1,2 Young-Joon Jo,
More informationRetinal nerve fiber layer thickness in Indian eyes with optical coherence tomography
Original articles in Indian eyes with optical coherence tomography Malik A, Singh M, Arya SK, Sood S, Ichhpujani P Department of Ophthalmology Government Medical College and Hospital, Sector 32, Chandigarh,
More informationOptical coherence tomography (OCT) is a noninvasive,
Ability of Stratus OCT to Detect Progressive Retinal Nerve Fiber Layer Atrophy in Glaucoma Eun Ji Lee, 1,2 Tae-Woo Kim, 1,2 Ki Ho Park, 2 Mincheol Seong, 3 Hyunjoong Kim, 4 and Dong Myung Kim 2 PURPOSE.
More informationOtticaFisiopatologica
Anno quindicesimo dicembre 2010 How to assess the retinal nerve fiber layer thickness Antonio Ferreras Miguel Servet University Hospital, Zaragoza. Aragón Health Sciences Institute University of Zaragoza
More informationDiagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City
Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing
More informationEvaluation of myopia on retinal nerve fiber layer thickness measured by Spectralis optical coherence tomography
2716 Evaluation of myopia on retinal nerve fiber layer thickness measured by Spectralis optical coherence tomography YI ZHA, JINFEI ZHUANG, DA LIN, WANGQIANG FENG, HAIHUA ZHENG and JIANQIU CAI Ophthalmology
More informationOCT Assessment of the Vitreoretinal Relationship in CSME
December 2007 Sonia Rani John et al. - IFIS 375 ORIGINAL ARTICLE OCT Assessment of the Vitreoretinal Relationship in CSME Dr. Manoj S. DNB FRCS, Dr. Unnikrishnan Nair MS DO FRCS, Dr. Gargi Sathish MS Introduction
More informationClinical and OCT features of different types and stages of diabetic optic neuropathy
Clinical and OCT features of different types and stages of diabetic optic neuropathy P.A. Bezditko 1, Dr Sc (Med), Prof.; M.A. Karliychuk 2, Cand Sc (Med) 1 Kharkiv National Medical University ; Kharkiv
More informationDiagnostic Accuracy of OCT with a Normative Database to Detect Diffuse Retinal Nerve Fiber Layer Atrophy: Diffuse Atrophy Imaging Study METHODS
Glaucoma Diagnostic Accuracy of OCT with a Normative Database to Detect Diffuse Retinal Nerve Fiber Layer Atrophy: Diffuse Atrophy Imaging Study Jin Wook Jeoung, 1,2 Seok Hwan Kim, 1,3 Ki Ho Park, 1,2
More informationResearch Article The Pattern of Retinal Nerve Fiber Layer and Macular Ganglion Cell-Inner Plexiform Layer Thickness Changes in Glaucoma
Hindawi Ophthalmology Volume 2017, Article ID 78365, 8 pages https://doi.org/10.1155/2017/78365 Research Article The Pattern of Retinal Nerve Fiber Layer and Macular Ganglion Cell-Inner Plexiform Layer
More informationReports. Macular Thickness as a Potential Biomarker of Mild Alzheimer s Disease
Reports Macular Thickness as a Potential Biomarker of Mild Alzheimer s Disease Although several postmortem findings in the retina of patients with Alzheimer s disease (AD) are available, 1 new biomarkers
More informationEvaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2011;25(4):238-242 DOI: 10.3341/kjo.2011.25.4.238 Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery Original
More informationMacular Ganglion Cell Complex Measurement Using Spectral Domain Optical Coherence Tomography in Glaucoma
Med. J. Cairo Univ., Vol. 83, No. 2, September: 67-72, 2015 www.medicaljournalofcairouniversity.net Macular Ganglion Cell Complex Measurement Using Spectral Domain Optical Coherence Tomography in Glaucoma
More informationStudy of Retinal Nerve Fiber Layer Thickness Within Normal Hemivisual Field in Primary Open-Angle Glaucoma and Normal-Tension Glaucoma
Study of Retinal Nerve Fiber Layer Thickness Within Normal Hemivisual Field in Primary Open-Angle Glaucoma and Normal-Tension Glaucoma Chiharu Matsumoto, Shiroaki Shirato, Mai Haneda, Hiroko Yamashiro
More informationA Formula to Predict Spectral Domain Optical Coherence Tomography (OCT) Retinal Nerve Fiber Layer Measurements Based on Time Domain OCT Measurements
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2012;26(5):369-377 http://dx.doi.org/10.3341/kjo.2012.26.5.369 Original Article A Formula to Predict Spectral Domain Optical Coherence Tomography (OCT)
More informationCOMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY
Original Article COMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY Aggarwal Somesh V 1, Shah Sonali N 2, Bharwada Rekha
More informationEXPERIMENTAL AND THERAPEUTIC MEDICINE 6: , 2013
268 Comparison of optic nerve morphology in eyes with glaucoma and eyes with non-arteritic anterior ischemic optic neuropathy by Fourier domain optical coherence tomography YUXIN YANG 1, HAITAO ZHANG 1,
More informationGanglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD
Ganglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD Figure 1. Normal OCT of the macula (cross section through the line indicated on the fundus photo)
More informationEthambutol (EMB), the first-line drug used to treat mycobacterium
Eye Movements, Strabismus, Amblyopia and Neuro-Ophthalmology Ganglion Cell Layer and Inner Plexiform Layer as Predictors of Vision Recovery in Ethambutol-Induced Optic Neuropathy: A Longitudinal OCT Analysis
More informationGanglion cell complex scan in the early prediction of glaucoma
Original article in the early prediction of glaucoma Ganekal S Nayana Super Specialty Eye Hospital and Research Center, Davangere, Karnataka, India Abstract Objective: To compare the macular ganglion cell
More informationInternational Journal of Scientific & Engineering Research, Volume 4, Issue 12, December ISSN
International Journal of Scientific & Engineering Research, Volume 4, Issue 12, December-2013 108 Name of Chief and Corresponding Author : Dr Chandrima Paul TITLE : Comparison of glaucoma diagnostic ability
More informationClinical Trials in Diabetic Retinopathy. Harry W. Flynn Jr., M.D. Nidhi Relhan Batra, M.D.
1 Clinical Trials in Diabetic Retinopathy 2018 Harry W. Flynn Jr., M.D. Nidhi Relhan Batra, M.D. Bascom Palmer Eye Institute 900 N.W. 17th Street Miami, FL 33136 Phone: (305) 326-6118 Fax: (305) 326-6417
More informationTo assess the glaucoma diagnostic ability of Fourier Domain Optical Coherence Tomography
American Journal of Engineering Research (AJER) e-issn : 2320-0847 p-issn : 2320-0936 Volume-02, Issue-11, pp-104-110 www.ajer.org Research Paper Open Access To assess the glaucoma diagnostic ability of
More informationAvailable online at Pelagia Research Library. Advances in Applied Science Research, 2013, 4(6):
Available online at www.pelagiaresearchlibrary.com Advances in Applied Science Research, 2013, 4(6):201-206 ISSN: 0976-8610 CODEN (USA): AASRFC Comparison of glaucoma diagnostic ability of retinal nerve
More informationOptical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.
Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Disclosure OCT Optical Coherence Tomography No relevant financial relationships I will refer to
More informationAndrew J. Barkmeier, MD; Benjamin P. Nicholson, MA; Levent Akduman, MD
c l i n i c a l s c i e n c e Effectiveness of Laser Photocoagulation in Clinically Significant Macular Edema With Focal Versus Diffuse Parafoveal Thickening on Optical Coherence Tomography Andrew J. Barkmeier,
More informationKyungmin Lee, Heeyoung Chung, Youngsuk Park, Joonhong Sohn. HanGil Eye Hospital, Incheon, Korea
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2014;28(4):298-305 http://dx.doi.org/10.3341/kjo.2014.28.4.298 Original Article Efficacy of Intravitreal Anti-vascular Endothelial Growth Factor or
More informationEvaluation of retinal nerve fiber layer thickness parameters in myopic population using scanning laser polarimetry (GDxVCC)
Dada T et al Original article Evaluation of retinal nerve fiber layer thickness parameters in myopic population using scanning laser polarimetry (GDxVCC) Dada T1, Aggarwal A1, Bali SJ2, Sharma A1, Shah
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Multivariate Analysis of Intravitreal Injection of Anti-VEGF Bevacizumab in the Treatment
More informationClinical Outcomes After Intravitreal Bevacizumab Injection for Diabetic Macular Edema
Original Article Clinical Outcomes After Intravitreal Bevacizumab Injection for Diabetic Macular Edema Karen Joyce G. Castro, MD, Marie Joan V. Loy, MD International Eye Institute St. Luke s Medical Center
More informationMethod for comparing visual field defects to local RNFL and RGC damage seen on frequency domain OCT in patients with glaucoma.
Method for comparing visual field defects to local RNFL and RGC damage seen on frequency domain OCT in patients with glaucoma. Donald C. Hood 1,2,* and Ali S. Raza 1 1 Department of Psychology, Columbia
More informationJong Chul Han, Da Ye Choi, and Changwon Kee. 1. Introduction
Ophthalmology Volume 2015, Article ID 641204, 7 pages http://dx.doi.org/10.1155/2015/641204 Clinical Study The Different Characteristics of Cirrus Optical Coherence Tomography between Superior Segmental
More informationJi Soo Shin, Young Hoon Lee. Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2017;31(6):497-507 https://doi.org/10.3341/kjo.2016.0108 Original Article Changes in Macular Retinal Layers and Peripapillary Nerve Fiber Layer Thickness
More informationNew Normative Database of Inner Macular Layer Thickness Measured by Spectralis OCT Used as Reference Standard for Glaucoma Detection
Article https://doi.org/10.1167/tvst.7.1.20 New Normative Database of Inner Macular Layer Thickness Measured by Spectralis OCT Used as Reference Standard for Glaucoma Detection María Nieves-Moreno 1,2,
More informationZEISS AngioPlex OCT Angiography. Clinical Case Reports
Clinical Case Reports Proliferative Diabetic Retinopathy (PDR) Case Report 969 PROLIFERATIVE DIABETIC RETINOPATHY 1 1-year-old diabetic female presents for follow-up of proliferative diabetic retinopathy
More informationPersistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment
9:30 AM Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment Lee Jampol, MD OBJECTIVE To assess subsequent visual and anatomic outcomes of eyes with
More informationOPTOMETRY RESEARCH PAPER
C L I N I C A L A N D E X P E R I M E N T A L OPTOMETRY RESEARCH PAPER Interocular symmetry of retinal nerve fibre layer thickness in healthy eyes: a spectral-domain optical coherence tomographic study
More informationScanning Laser Polarimetry and Optical Coherence Tomography for Detection of Retinal Nerve Fiber Layer Defects
접수번호 : 2008-105 Korean Journal of Ophthalmology 2009;23:169-175 ISSN : 1011-8942 DOI : 10.3341/kjo.2009.23.3.169 Scanning Laser Polarimetry and Optical Coherence Tomography for Detection of Retinal Nerve
More informationDiabetic Retinopatathy
Diabetic Retinopatathy Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl Zeiss Meditec Arctic DX Macula Risk Advanced
More informationIntravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema
Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema Young Jae Choi, MD, In Kyung Oh, MD, Jae Ryung Oh, MD, PhD, Kuhl Huh, MD, PhD Department of Ophthalmology,
More informationProgressive glaucomatous optic disc atrophy is characterized
Glaucoma Longitudinal Analysis of Progression in Glaucoma Using Spectral-Domain Optical Coherence Tomography Julia M. Wessel, 1 Folkert K. Horn, 1 Ralf P. Tornow, 1 Matthias Schmid, 2 Christian Y. Mardin,
More informationResearch Article Repeatability of Perimacular Ganglion Cell Complex Analysis with Spectral-Domain Optical Coherence Tomography
Ophthalmology Volume 2015, Article ID 605940, 5 pages http://dx.doi.org/10.1155/2015/605940 Research Article Repeatability of Perimacular Ganglion Cell Complex Analysis with Spectral-Domain Optical Coherence
More informationPosition of retinal blood vessels correlates with retinal nerve fibre layer thickness profiles as measured with GDx VCC and ECC
Department of Ophthalmology, Medical University of Vienna, Austria Correspondence to Clemens Vass, Department of Ophthalmology and Optometry, Medical University of Vienna, General Hospital, Währinger Gürtel
More informationRelationship between the GDx VCC and Stratus OCT in Primary Open Angle Glaucoma
Relationship between the GDx VCC and Stratus OCT in Primary Open Angle Glaucoma Reza Zarei, MD 1 Mohammad Soleimani, MD 2 Sasan Moghimi, MD 3 Mohammad Yaser Kiarudi, MD 2 Mahmoud Jabbarvand, MD 1 Yadollah
More informationDifferences between Non-arteritic Anterior Ischemic Optic Neuropathy and Open Angle Glaucoma with Altitudinal Visual Field Defect
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2015;29(6):418-423 http://dx.doi.org/10.3341/kjo.2015.29.6.418 Original Article Differences between Non-arteritic Anterior Ischemic Optic Neuropathy
More informationMeasurement of Choroidal Thickness in Normal Eyes Using 3D OCT-1000 Spectral Domain Optical Coherence Tomography
pissn: 111-8942 eissn: 292-9382 Korean J Ophthalmol 212;26(4):255-259 http://dx.doi.org/1.3341/kjo.212.26.4.255 Original Article Measurement of Choroidal Thickness in Normal Eyes Using 3D OCT-1 Spectral
More informationNoel de Jesus Atienza, MD, MSc and Joseph Anthony Tumbocon, MD
Original Article Philippine Journal of OPHTHALMOLOGY Diagnostic Accuracy of the Optical Coherence Tomography in Assessing Glaucoma Among Filipinos. Part 1: Categorical Outcomes Based on a Normative Database
More informationPatterns of Subsequent Progression of Localized Retinal Nerve Fiber Layer Defects on Red-free Fundus Photographs in Normal-tension Glaucoma
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2014;28(4):330-336 http://dx.doi.org/10.3341/kjo.2014.28.4.330 Original Article Patterns of Subsequent Progression of Localized Retinal Nerve Fiber
More informationOptical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
Columbia International Publishing Journal of Ophthalmic Research (2014) Research Article Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
More informationParafoveal Scanning Laser Polarimetry for Early Glaucoma Detection
Yamanashi Med. J. 18(1), 15~ 20, 2003 Original Article Parafoveal Scanning Laser Polarimetry for Early Glaucoma Detection Satoshi KOGURE, Yoshiki TODA, Hiroyuki IIJIMA and Shigeo TSUKAHARA Department of
More informationNew Concepts in Glaucoma Ben Gaddie, OD Moderator Murray Fingeret, OD Louis Pasquale, MD
New Concepts in Glaucoma Ben Gaddie, OD Moderator Murray Fingeret, OD Louis Pasquale, MD New Concepts in Glaucoma Optical Coherence Tomography: Is it necessary and needed to diagnose and monitor glaucoma?
More informationCorrespondence should be addressed to Verena Prokosch;
Hindawi Ophthalmology Volume 2017, Article ID 8014294, 6 pages https://doi.org/10.1155/2017/8014294 Research Article Comparison between the Correlations of Retinal Nerve Fiber Layer Thickness Measured
More informationCLINICAL SCIENCES. Comparison of Glaucoma Diagnostic Capabilities of Cirrus HD and Stratus Optical Coherence Tomography
CLINICAL SCIENCES Comparison of Glaucoma Diagnostic Capabilities of Cirrus HD and Stratus Optical Coherence Tomography Seong Bae Park, MD; Kyung Rim Sung, MD, PhD; Sung Yong Kang, MD; Kyung Ri Kim, BS;
More informationDiabetic Retinopathy Clinical Research Network
Diabetic Retinopathy Clinical Research Network Comparison of Time Domain OCT and Spectral Domain OCT Retinal Thickness Measurement in Diabetic Macular Edema Version 1.0 June 16, 2009 comparison of td vs
More informationComparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements
Original article Comparative evaluation of time domain and spectral domain optical coherence tomography in retinal nerve fiber layer thickness measurements Dewang Angmo, 1 Shibal Bhartiya, 1 Sanjay K Mishra,
More informationCLINICAL SCIENCES. Repeatability and Reproducibility of Fast Macular Thickness Mapping With Stratus Optical Coherence Tomography
CLINICAL SCIENCES Repeatability and Reproducibility of Fast Macular Thickness Mapping With Stratus Optical Coherence Tomography Antonio Polito, MD; Michele Del Borrello, MD; Miriam Isola, MHS; Nicola Zemella,
More informationClinical Features of Pregnancy-associated Retinal and Choroidal Diseases Causing Acute Visual Disturbance
pissn: 0-8942 eissn: 2092-9382 Korean J Ophthalmol 207;3(4):320-327 https://doi.org/0.334/kjo.206.0080 Original Article Clinical Features of Pregnancy-associated Retinal and Choroidal Diseases Causing
More informationFacts About Diabetic Eye Disease
Facts About Diabetic Eye Disease Points to Remember 1. Diabetic eye disease comprises a group of eye conditions that affect people with diabetes. These conditions include diabetic retinopathy, diabetic
More informationAssessment of Retinal Nerve Fiber Layer Changes by Cirrus High-definition Optical Coherence Tomography in Myopia
Divya Singh et al Original REASEARCH 10.5005/jp-journals-10028-1223 Assessment of Retinal Nerve Fiber Layer Changes by Cirrus High-definition Optical Coherence Tomography in Myopia 1 Divya Singh, 2 Sanjay
More informationTitle: OCT Analysis Workshop: Interpretation of OCT printouts
Title: OCT Analysis Workshop: Interpretation of OCT printouts Authors: David Yang, OD, FAAO Staff Optometrist, VA Palo Alto Health Care System Associate Clinical Professor, UC Berkeley School of Optometry
More informationMATERIALS AND METHODS
Glaucoma Analysis of Peripapillary Retinal Nerve Fiber Distribution in Normal Young Adults Seung Woo Hong, 1,2 Myung Douk Ahn, 2 Shin Hee Kang, 1,3 and Seong Kyu Im 1,4 PURPOSE. To determine the anatomic
More informationOptical coherence tomography in diabetic macular edema: patterns and related risk factors
Original article Optical coherence tomography in diabetic macular edema: patterns and related risk factors Mohammadreza Ahmadpour-Baghdadabad Masoudreza Manaviat Ahmad Shojaoddiny-Ardekani Yazd Diabetes
More informationEyes on Diabetics: How to Avoid Blindness in Diabetic Patient
Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient Rova Virgana FK Unpad Pusat Mata Nasional RS Mata Cicendo Bandung Eye Center (Hospital and Clinic) PIT IDI Jabar 2018 Keys Facts from WHO
More informationR&M Solutions
Mohamed Hosny El-Bradey, MD., Assistant Professor of Ophthalmology, Tanta University. Wael El Haig, MD., Professor of Ophthalmology. Zagazeeg University. 1 Myopic CNV is considered the most common vision
More informationMeasurement of Subfoveal Choroidal Thickness Using Spectral Domain Optical Coherence Tomography
c l i n i c a l s c i e n c e Measurement of Subfoveal Choroidal Thickness Using Spectral Domain Optical Coherence Tomography Emily A. McCourt, MD; Brian C. Cadena, PhD; Cullen J. Barnett, CRA; Antonio
More informationDiabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion
European Journal of Ophthalmology / Vol. 13 no. 7, 2003 / pp. 648-652 Diabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion J. SWART 1,2, J.W. REICHERT-THOEN 1, M.S.
More informationUniversity Hospital Basel. Optical Coherence Tomography Emerging Role in the Assessment of MS PD Dr. Konstantin Gugleta
University Hospital Basel Optical Coherence Tomography Emerging Role in the Assessment of MS PD Dr. Konstantin Gugleta 15th State of the Art SMSS, Lucerne January 2013 Retinal Nerve Fiber Layer 1.200.000
More informationMyopia is a major cause of visual impairment in many
Retina Association between Choroidal Morphology and Anti- Vascular Endothelial Growth Factor Treatment Outcome in Myopic Choroidal Neovascularization Seong Joon Ahn, 1 Se Joon Woo, 1 Ko Eun Kim, 2 and
More informationCHAPTER 13 CLINICAL CASES INTRODUCTION
2 CHAPTER 3 CLINICAL CASES INTRODUCTION The previous chapters of this book have systematically presented various aspects of visual field testing and is now put into a clinical context. In this chapter,
More informationPART 1: GENERAL RETINAL ANATOMY
PART 1: GENERAL RETINAL ANATOMY General Anatomy At Ora Serrata At Optic Nerve Head Fundoscopic View Of Normal Retina What Is So Special About Diabetic Retinopathy? The WHO definition of blindness is
More informationHistory/principles of the OCT What does the normal retinal OCT look like Vitreal disorders Retinal/RPE disorders Choroidal disorders
Nathan Lighthizer, O.D., F.A.A.O. Assistant Professor Assistant Dean for Clinical Care Director of Continuing Education Chief of Specialty Care Clinics Chief of Electrodiagnostics Clinic Oklahoma College
More informationmeasure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control
More informationThickness Changes in the Fovea and Peripapillary Retinal Nerve Fiber Layer Depend on the Degree of Myopia
Thickness Changes in the Fovea and Peripapillary Retinal Nerve Fiber Layer Depend on the Degree of Myopia Sung-Won Choi, MD, Seok-Joon Lee, MD Department of Ophthalmology, Wonju Christian Hospital. Yonsei
More informationINTRODUCTION. Trans Am Ophthalmol Soc 2010;108:62-76
INTERPRETING THICKNESS CHANGES IN THE DIABETIC MACULA: THE PROBLEM OF SHORT- TERM VARIATION IN OPTICAL COHERENCE TOMOGRAPHY MEASURED MACULAR THICKENING (AN AMERICAN OPHTHALMOLOGICAL SOCIETY THESIS) BY
More informationOCT in the Diagnosis and Follow-up of Glaucoma
OCT in the Diagnosis and Follow-up of Glaucoma Karim A Raafat MD. Professor Of Ophthalmology Cairo University Hmmmm! Do I have Glaucoma or not?! 1 Visual Function 100% - N Gl Structure : - 5000 axon /
More informationNon-arteritic anterior ischemic optic neuropathy (NAION) with segmental optic disc edema. Jonathan A. Micieli, MD Valérie Biousse, MD
Non-arteritic anterior ischemic optic neuropathy (NAION) with segmental optic disc edema Jonathan A. Micieli, MD Valérie Biousse, MD A 75 year old white woman lost vision in the inferior part of her visual
More informationSubclinical Diabetic Macular Edema Study
Diabetic Retinopathy Clinical Research Network Subclinical Diabetic Macular Edema Study Version 2.0 March 21, 2006 Subclinical DME Protocol v2 0 3-21-06.doc Table of Contents Chapter 1. Background Information
More informationCirrus TM HD-OCT. Details defi ne your decisions
Cirrus TM HD-OCT Details defi ne your decisions 2 With high-defi nition OCT Carl Zeiss Meditec takes you beyond standard spectral domain Built on 10 years experience at the vanguard of innovation, Carl
More informationSeiji T. Takagi, Yoshiyuki Kita, Asuka Takeyama, and Goji Tomita. 1. Introduction. 2. Subjects and Methods
Ophthalmology Volume 2011, Article ID 914250, 5 pages doi:10.1155/2011/914250 Clinical Study Macular Retinal Ganglion Cell Complex Thickness and Its Relationship to the Optic Nerve Head Topography in Glaucomatous
More information53 year old woman attends your practice for routine exam. She has no past medical history or family history of note.
Case 1 Normal Tension Glaucoma 53 year old woman attends your practice for routine exam. She has no past medical history or family history of note. Table 1. Right Eye Left Eye Visual acuity 6/6 6/6 Ishihara
More informationDexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2017;31(2):108-114 https://doi.org/10.3341/kjo.2017.31.2.108 Original Article Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory
More informationElevated intraocular pressure (IOP) is a major risk factor for
Glaucoma The Association between Retinal Vessel Diameter and Retinal Nerve Fiber Layer Thickness in Asymmetric Normal Tension Glaucoma Patients Joon Mo Kim, 1 Mo Sae Kim, 2 Hyo Ju Jang, 1 Ki Ho Park, 3
More informationReproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using Spectral Domain Optical Coherence Tomography
ORIGINAL STUDY Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using Spectral Domain Optical Coherence Tomography Huijuan Wu, MD, PhD,*w Johannes F. de Boer, PhD,z and Teresa C. Chen,
More informationClinical Study Evaluation of Peripapillary Nerve Fiber Layer after Dexamethasone Implantation (Ozurdex) in Branch Retinal Vein Occlusions
Ophthalmology Volume 2016, Article ID 2050796, 4 pages http://dx.doi.org/10.1155/2016/2050796 Clinical Study Evaluation of Peripapillary Nerve Fiber Layer after Dexamethasone Implantation (Ozurdex) in
More informationRelationship Between Structure
Original Article Relationship Between Structure and Function of the Optic Nerve Head-Glaucoma versus Normal Dr Savita Bhat, Dr Anna Elias, Dr Siddharth Pawar, Dr S.J. Saikumar, Dr Alpesh Rajput, superior,
More informationDiabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series
Diabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series Joseph J. Pizzimenti, OD, FAAO Associate Professor Nova Southeastern University The Eye Care Institute pizzimen@nova.edu
More informationFundus Fluorescein Angiography in Diabetic Retinopathy: Correlation of Angiographic Findings to the Clinical Maculopathy Abstract: Purpose:
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 2 Ver. XII (Feb. 2016), PP 80-88 www.iosrjournals.org Fundus Fluorescein Angiography in Diabetic
More informationRETINAL NERVE FIBER LAYER
CLINICAL SCIENCES The Effect of Scan Diameter on Retinal Nerve Fiber Layer Thickness Measurement Using Stratus Optic Coherence Tomography Giacomo Savini, MD; Piero Barboni, MD; Michele Carbonelli, MD;
More informationResearch Article http://www.alliedacademies.org/clinical-ophthalmology-and-vision-science/ The trial: A pilot study to assess the efficacy, durability, and safety of combination ranibizumab + peripheral
More information